Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Toxins

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PSMC5 insufficiency and P320R mutation impair proteasome function.

Human molecular genetics·2024

Same author

Maximum entropy determination of mammalian proteome dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2024

Same author

Molecular mechanism for activation of the 26S proteasome by ZFAND5.

Molecular cell·2023

Same author

Molecular mechanisms for activation of the 26S proteasome.

bioRxiv : the preprint server for biology·2023

Same author

26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase.

Proceedings of the National Academy of Sciences of the United States of America·2022

Same author

Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation.

The Journal of biological chemistry·2022

Search research articles

Related Experiment Video

Updated: May 18, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Bacterial proteolytic complexes as therapeutic targets.

Ravikiran M Raju¹, Alfred L Goldberg, Eric J Rubin

¹Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02138, USA.

Nature Reviews. Drug Discovery

|October 2, 2012

Summary

This summary is machine-generated.

Bacterial proteases are promising targets for new antibacterial drugs due to their essential roles in bacterial growth and virulence. Developing specific modulators for these proteases presents challenges but offers a novel approach to combat antibiotic resistance.

More Related Videos

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Published on: November 12, 2012

Related Experiment Videos

Last Updated: May 18, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Published on: November 12, 2012

Area of Science:

Biochemistry
Microbiology
Drug Discovery

Background:

Proteases are validated drug targets for various diseases, including hypertension, diabetes, and viral infections.
The rise of antibiotic resistance necessitates novel therapeutic strategies.
Intracellular bacterial degradative proteases are essential for bacterial survival and virulence, making them attractive antibacterial targets.

Purpose of the Study:

To review the roles of key prokaryotic degradative proteases.
To summarize initial efforts in developing therapeutic modulators for these proteases.
To highlight the challenges associated with creating novel antibacterial drugs targeting proteases.

Main Methods:

Literature review of existing research on bacterial proteases and antibacterial drug development.
Analysis of the pharmacological tractability of proteases as drug targets.
Identification of key prokaryotic degradative proteases and their functions.

Main Results:

Proteases have a proven track record as drug targets in other therapeutic areas.
Intracellular bacterial degradative proteases are crucial for bacterial growth and virulence.
Early-stage efforts to develop protease inhibitors as antibacterials have been initiated.

Conclusions:

Bacterial proteases represent a promising, yet underexplored, class of targets for novel antibacterial agents.
Overcoming challenges in developing specific protease modulators is key to realizing their therapeutic potential.
Targeting bacterial proteases offers a potential new avenue to combat the growing threat of antibiotic resistance.